title: Imiquimod contact pemphigus: a comment.
authors.forename: Eleonora
authors.initials: E
authors.lastname: Ruocco
authors.forename: Adone
authors.initials: A
authors.lastname: Baroni
authors.forename: Luigi
authors.initials: L
authors.lastname: Rossiello
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Ruocco
mesh_terms: D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000634:Aminoquinolines / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002278:Carcinoma in Situ / Q000188:drug therapy; D002990:Clobetasol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000009:adverse effects; D005260:Female; D006801:Humans; D000077271:Imiquimod; D030361:Papillomavirus Infections / Q000188:drug therapy; D010392:Pemphigus / Q000139:chemically induced* / Q000188:drug therapy; D016896:Treatment Outcome; D014845:Vulvar Diseases / Q000188:drug therapy*; D014846:Vulvar Neoplasms / Q000188:drug therapy
chemical_list: D000305:Adrenal Cortex Hormones; D000634:Aminoquinolines; D000970:Antineoplastic Agents; D003276:Contraceptives, Oral; C010893:clobetasone butyrate; D002990:Clobetasol; D000077271:Imiquimod